Document Type

Article

Publication Date

6-17-2024

Comments

This article is the author’s final published version in Pulmonary Circulation, Volume 14, Issue 2, Apr 2024, Article number e12401.

The published version is available at https://doi.org/10.1002/pul2.12401. Copyright © 2024 The Authors. Pulmonary Circulation published by John Wiley & Sons Ltd on behalf of Pulmonary Vascular Research Institute.

Publication made possible in part by support through a transformative agreement between Thomas Jefferson University and the publisher.

Abstract

Pulmonary hypertension (PH) is associated with adverse outcomes in chronic kidney disease (CKD) patients. Our study suggests mildly elevated pulmonary vascular resistance ( > 2 to ≤ 3) is independently associated with major adverse cardiovascular events at 1-year follow-up. Early diagnosis of precapillary PH in CKD patients can potentially improve clinical outcomes.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License

Language

English

Share

COinS